Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.

Fernando BrilMichael J McPhaulSrilaxmi KalavalapalliRomina LomonacoDiana BarbMeagan E GrayDov ShiffmanCharles M RowlandKenneth Cusi

Published in: The Journal of clinical endocrinology and metabolism (2021)

In patients without diabetes, accurate measurement of fasting intact insulin levels by mass spectrometry constitutes an easy and noninvasive strategy to predict presence of NAFLD.

Keyphrases

type diabetes
end stage renal disease
mass spectrometry
newly diagnosed
ejection fraction
chronic kidney disease
glycemic control
cardiovascular disease
peritoneal dialysis
prognostic factors
gene expression
adipose tissue
skeletal muscle
high performance liquid chromatography
capillary electrophoresis